NCT06014346

Brief Summary

The prevention of vasovagal reactions (VVR) occurring during or after donation is a major issue for the French Blood Establishment (EFS), firstly to guarantee the safety of donors but also to retain them, as this reaction is one of the negative experiences affecting the return to donation. The EVASION study conducted in the Auvergne Rhône-Alpes region (AURA) on 4828 donors representative of the French donor population, reported a beneficial effect of muscle contraction exercises to prevent the occurrence of VVR during donation, while hydric solutions, and even more so isotonic solutions, were likely to decrease the frequency of delayed VVR. These preventive measures have been integrated into the internal guidelines and currently include muscular and breathing exercises and hydration. Nevertheless, the isotonic solution could not be routinely deployed for feasibility and cost reasons. A salty snack could replace the isotonic solution to produce the same effects with better feasibility and acceptability. Furthermore, a significant proportion of discomfort is psychological in origin, related to stress and anxiety which persist despite these measures, particularly in the first-time donor population. These measures, which are mainly focused on the prevention of VVR of physiological origin, are still insufficient and can be optimized and complemented to reduce the occurrence of VVR, especially in first-time donors for whom anxiety and stress play an important role in the etiology of VVR. Two measures could further reduce the occurrence of VVR:

  • Reinforcement of the physiological strategy: ingestion of a salty snack before donation, the effect of which could be similar to the effect of the isotonic solution, which could not be delivered in practice because of its cost following the data of the EVASION study.
  • Addition of a psychological strategy: flyer given at the interview presenting the four most frequent fears as well as a description of the recommended muscular and respiratory exercises, followed by the execution of the recommended exercises before the sampling. Hypothesis is that the combination of a psychological and physiological strategies would allow a reduction of the occurrence of immediate and/or 48 h delayed VVR during the whole blood donation in first time donors compared to the current practices.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,320

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Oct 2023Aug 2026

First Submitted

Initial submission to the registry

August 21, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 28, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 10, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2026

Expected
Last Updated

October 4, 2023

Status Verified

September 1, 2023

Enrollment Period

1.6 years

First QC Date

August 21, 2023

Last Update Submit

October 2, 2023

Conditions

Keywords

first time donorwhole blood donationvasovagal ReactionphysiologicalpsychologicalBDRIBDAS

Outcome Measures

Primary Outcomes (1)

  • Vasovagal reactions (VVR)

    Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by both psychological and physiological strategies (group 4) compared to usual standard practices (group 1)

    Day 1 = donation day ; Day 3 = 48h post donation

Secondary Outcomes (9)

  • VVR psychological strategy

    Day 1 = donation day ; Day 3= 48h post donation

  • VVR physiological strategy

    Day 1 = donation day ; Day 3= 48h post donation

  • Immediate VVR

    Day 1 = donation day, before leaving the centre

  • Delayed VVR

    Day 3= 48h post donation

  • First-time donor adherence

    Day 1 = donation day, before leaving the centre

  • +4 more secondary outcomes

Study Arms (4)

Control group

NO INTERVENTION

EFS usual standard practices for the whole blood donation

Test Group 1

EXPERIMENTAL

A psychological strategy is added to EFS standard practices before the whole blood donation * flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises, * followed by a training of these exercises and their execution

Other: Psychological strategy

Test Group 2

EXPERIMENTAL

A physiological strategy is added to EFS standard practices before the whole blood donation : - Ingesting a salty snack.

Other: Physiological strategy

Test group 3

EXPERIMENTAL

The both psychological and physiological strategies are added to EFS standard practices before the whole blood donation * flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises, * followed by a training of these exercises and their execution Ingesting a salty snack.

Other: Psychological strategyOther: Physiological strategy

Interventions

* flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises, * then realization accompanied by a training of these exercises

Test Group 1Test group 3

\- ingesting a salty snack

Test Group 2Test group 3

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • M/F between 18 and 70 years old,
  • A first-time donor who wishes to donate blood in Lyon, either at a fixed site or at a mobile unit,
  • Declared fit to donate whole blood after the EFS pre-donation interview,
  • Weight ≥ 50kg and height ≥ 135 cm,
  • Available for telephone contact between to 5d +/- 2 days after donation,
  • Having signed a written consent to participate in the study.
  • Known allergy to shellfish, and/or gluten, and/or milk, and/or soy,
  • Incomprehension of the French language,
  • First-time donor under protective measures (guardian, curator) or any other administrative measure,
  • Not affiliated to the French social security system or any other equivalent system,
  • Pregnant or breastfeeding woman,
  • Subject participating in any other interventional or non-interventional research

You may not qualify if:

  • Withdrawal of consent
  • First-time donor with anemia following routine hemoglobin testing
  • First-time donor not reachable for telephone interview

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

French Blood Establishment (EFS)

Lyon, 69153, France

Location

MeSH Terms

Conditions

Syncope, Vasovagal

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesSyncopeUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Julie MD-PhD HAESEBAERT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2023

First Posted

August 28, 2023

Study Start

October 10, 2023

Primary Completion

May 18, 2025

Study Completion (Estimated)

August 18, 2026

Last Updated

October 4, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations